WT1 and cancer: Wilms’ tumor 1 (WT1) is widely recognized as one of the most prevalent cancer antigens and holds the top rank according to the cancer antigen pilot prioritization: criteria and sub-criteria definitions and weightings, which was published by the National Cancer Institute (NCI) in the United States [16].